Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "bone resorption pathway" is a cellular and molecular process by which bone tissue is actively degraded by specialized cells known as osteoclasts. The process involves recruitment and differentiation of osteoclast precursors (regulated by signals such as RANKL, CSF-1, and cytokines), localization of mature osteoclasts to bone surfaces, acidification and proteolytic digestion of bone mineral and matrix through proton pumps (vacuolar-type ATPases), chloride channels, carbonic anhydrase, and cathepsin K protease, and subsequent removal of the degradation products by endocytosis. The pathway serves critical roles in bone remodeling, calcium and phosphate homeostasis, and adaption to stress and injury[1][3][4][5]. Dysregulation leads to diseases of bone loss or excessive bone formation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone resorption pathway.